The CD48 receptor mediates Staphylococcus aureus human and murine eosinophil activation

Clinical and Experimental Allergy

Volumn 44, Issue 11, 2014, Pages 1335-1346

  Minai Fleminger, Y ^a   Gangwar, R S ^a   Migalovich Sheikhet, H ^a   Seaf, M ^a   Leibovici, V ^b   Hollander, N ^c   Feld, M ^d   Moses, A E ^b   Homey, B ^d   Levi Schaffer, F ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Staphylococcus aureus; Atopic dermatitis; CD48; Eosinophils; Mast cells; Peptidoglycan; Peritonitis; Protein A; Staphylococcus aureus enterotoxin B

Indexed keywords

CD48 ANTIGEN; PEPTIDOGLYCAN; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS PROTEIN A; ENTEROTOXIN; ENTEROTOXIN B, STAPHYLOCOCCAL; INTERLEUKIN 10; INTERLEUKIN 8; LEUKOCYTE ANTIGEN; PROTEIN BINDING;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL VIABILITY; CONFOCAL MICROSCOPY; CYTOKINE RELEASE; DEGRANULATION; EOSINOPHIL; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LEUKOCYTE; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM CELL; PERITONITIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; ANIMAL; ATOPIC DERMATITIS; BACTERIUM ADHERENCE; BONE MARROW CELL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; SKIN; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIGENS, CD; BACTERIAL ADHESION; BONE MARROW CELLS; CELL DEGRANULATION; DERMATITIS, ATOPIC; ENTEROTOXINS; EOSINOPHILS; GENE EXPRESSION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; LEUKOCYTES; MICE; MICE, KNOCKOUT; PERITONITIS; PROTEIN BINDING; SIGNAL TRANSDUCTION; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84922271975     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12422     Document Type: Article

References (48)

1. Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008; 454:445-54.
2. Bloemen K, Verstraelen S, Van Den Heuvel R, Witters H, Nelissen I, Schoeters G. The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett 2007; 113:6-18.
3. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24:147-74.
4. Hogan SP, Waddell A, Fulkerson PC. Eosinophils in infection and intestinal immunity. Curr Opin Gastroenterol 2013; 29:7-14.
5. Krakauer T. Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock. Toxins 2010; 2:1963-83.
6. Kong HH, Oh J, Deming C et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 22:850-9.
7. Pastacaldi C, Lewis P, Howarth P. Staphylococci and staphylococcal superantigens in asthma and rhinitis: a systematic review and meta-analysis. Allergy 2011; 66:549-55.
8. McFadden JP, Noble WC, Camp RD. Superantigenic exotoxin-secreting potential of staphylococci isolated from atopic eczematous skin. Br J Dermatol 1993; 128:631-2.
9. Skov L, Olsen JV, Giorno R, Schlievert PM, Baadsgaard O, Leung DY. Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. J Allergy Clin Immunol 2000; 105:820-6.
10. Wedi B, Wieczorek D, Stunkel T, Breuer K, Kapp A. Staphylococcal exotoxins exert proinflammatory effects through inhibition of eosinophil apoptosis, increased surface antigen expression (CD11b, CD45, CD54, and CD69), and enhanced cytokine-activated oxidative burst, thereby triggering allergic inflammatory reactions. J Allergy Clin Immunol 2002; 109:477-84.
11. Wong CK, Cheung PF, Ip WK, Lam CW. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol 2007; 37:85-96.
12. Sabroe I, Jones EC, Usher LR, Whyte MK, Dower SK. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 2002; 168:4701-10.
13. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999; 274:17406-9.
14. Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 2003; 4:19-24.
15. Smith GM, Biggs J, Norris B, Anderson-Stewart P, Ward R. Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis. J Clin Immunol 1997; 17:502-9.
16. Malaviya R, Gao Z, Thankavel K, van der Merwe PA, Abraham SN. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci USA 1999; 96:8110-5.
17. Munoz S, Hernandez-Pando R, Abraham SN, Enciso JA. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol 2003; 170:5590-6.
18. Rocha-de-Souza CM, Berent-Maoz B, Mankuta D, Moses AE, Levi-Schaffer F. Human mast cell activation by Staphylococcus aureus: interleukin-8 and tumor necrosis factor alpha release and the role of Toll-like receptor 2 and CD48 molecules. Infect Immun 2008; 76:4489-97.
19. Elishmereni M, Alenius HT, Bradding P et al. Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro. Allergy 2011; 66:376-85.
20. Elishmereni M, Bachelet I, Ben-Efraim AH, Mankuta D, Levi-Schaffer F. Interacting mast cells and eosinophils acquire an enhanced activation state in vitro. Allergy 2013; 68:171-9.
21. Munitz A, Bachelet I, Eliashar R et al. CD48 is an allergen and IL-3-induced activation molecule on eosinophils. J Immunol 2006; 177:77-83.
22. Munitz A, Bachelet I, Levi-Schaffer F. CD48 as a novel target in asthma therapy. Recent Pat Inflammation Allergy Drug Discovery 2007; 1:9-12.
23. Munoz NM, Leff AR. Highly purified selective isolation of eosinophils from human peripheral blood by negative immunomagnetic selection. Nat Protoc 2006; 1:2613-20.
24. Dyer KD, Moser JM, Czapiga M, Siegel SJ, Percopo CM, Rosenberg HF. Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow. J Immunol 2008; 181:4004-9.
25. Adamko DJ, Wu Y, Ajamian F, Ilarraza R, Moqbel R, Gleich GJ. The effect of cationic charge on release of eosinophil mediators. J Allergy Clin Immunol 2008; 122:383-90, 90 e1-4.
26. Hosoki K, Nakamura A, Nagao M et al. Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor. J Leukoc Biol 2012; 92:333-41.
27. Herz U, Ruckert R, Wollenhaupt K et al. Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness-a model for non-allergic asthma. Eur J Immunol 1999; 29:1021-31.
28. Bien J, Sokolova O, Bozko P. Characterization of virulence factors of Staphylococcus aureus: novel function of known virulence factors that are implicated in activation of airway epithelial proinflammatory response. J Pathog 2011; 2011:601905.
29. Uhlen M, Guss B, Nilsson B, Gatenbeck S, Philipson L, Lindberg M. Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem 1984; 259:1695-702.
30. Munitz A, Bachelet I, Fraenkel S et al. 2B4 (CD244) is expressed and functional on human eosinophils. J Immunol 2005; 174:110-8.
31. El-Shazly AE, Henket M, Lefebvre PP, Louis R. 2B4 (CD244) is involved in eosinophil adhesion and chemotaxis, and its surface expression is increased in allergic rhinitis after challenge. Int J Immunopathol Pharmacol 2011; 24:949-60.
32. Hatano Y, Taniuchi S, Masuda M et al. Phagocytosis of heat-killed Staphylococcus aureus by eosinophils: comparison with neutrophils. Apmis 2009; 117:115-23.
33. Yousefi S, Gold JA, Andina N et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 2008; 14:949-53.
34. Cheung PF, Wong CK, Ip WK, Lam CW. FAK-mediated activation of ERK for eosinophil migration: a novel mechanism for infection-induced allergic inflammation. Int Immunol 2008; 20:353-63.
35. Jong EC, Henderson WR, Klebanoff SJ. Bactericidal activity of eosinophil peroxidase. J Immunol 1980; 124:1378-82.
36. Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, Gleich GJ. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 1989; 142:4428-34.
37. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003; 170:3369-76.
38. Hammond MEW, Lapointe GR, Feucht PH et al. Il-8 Induces neutrophil chemotaxis predominantly via type-I Il-8 receptors. J Immunol 1995; 155:1428-33.
39. Parcina M, Miranda-Garcia MA, Durlanik S et al. Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-Producing B cells in response to Staphylococcus aureus. J Immunol 2013; 190:1591-602.
40. Wang JE, Jorgensen PF, Almlof M et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun 2000; 68:3965-70.
41. Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med 2008; 8:437-45.
42. Kumar A, Zhang J, Yu FS. Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci 2004; 45:3513-22.
43. Pan ZK. Toll-like receptors and TLR-mediated signaling: more questions than answers. Am J Physiol Lung Cell Mol Physiol 2004; 286:L918-20.
44. Gupta D, Jin YP, Dziarski R. Peptidoglycan induces transcription and secretion of TNF-alpha and activation of lyn, extracellular signal-regulated kinase, and rsk signal transduction proteins in mouse macrophages. J Immunol 1995; 155:2620-30.
45. Deane JA, Fruman DA. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 2004; 22:563-98.
46. Garnett D, Barclay AN, Carmo AM, Beyers AD. The association of the protein tyrosine kinases p56lck and p60fyn with the glycosyl phosphatidylinositol-anchored proteins Thy-1 and CD48 in rat thymocytes is dependent on the state of cellular activation. Eur J Immunol 1993; 23:2540-4.
47. Gonzalez-Cabrero J, Wise CJ, Latchman Y, Freeman GJ, Sharpe AH, Reiser H. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci USA 1999; 96:1019-23.
48. Lee KM, Forman JP, McNerney ME et al. Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions. Blood 2006; 107:3181-8.